FDA Committed To Third-Party Review, Henney Tells Senate HELP Committee

FDA Commissioner Jane Henney is "puzzled" about the low utilization rate within the device industry of the agency's "Accredited Persons" third-party premarket review program, she said at an Oct. 21 Senate Health, Education, Labor and Pensions Committee hearing.

More from Archive

More from Medtech Insight